The following patients were excluded: one who received a blood transfusion during COVID-19, two who received granulocyte-colony stimulating factor, two who developed infections (febrile thrombophlebitis and febrile neutropenia), and one who exhibited exacerbation of macroglobulinemia. This evidence concerns the gene CSF3 and macroglobulinemia.